Introduction Uterine carcinosarcoma (UC), previously known as malignant mixed mullerian tumour (MMMT), is a rare uterine neoplasm containing both carcinomatous and sarcomatous components. It is an aggressive subtype of endometrial carcinoma associated with late diagnosis and poor prognosis, representing less than 5% of all uterine malignancies while accounting for more than 15% of uterine cancer related deaths. Due to the relatively low incidence of cases, the optimal management of these patients following primary surgical treatment remains uncertain. Objective To review the characteristics, treatment and outcomes of a cohort of cases of UC. Methods 92 cases of UC were identified from a retrospective observational study of patients whose primary operations were performed by four gynaeoncologists at Monash Health from 1994 to 2016 inclusive. Patient characteristics, histopathology reports, type(s) of adjuvant therapy, presence of recurrence and survival status were extracted from patient records. Staging was determined based on histopathology using the International Federation of Gynaecology and Obstetrics (FIGO) staging system. Results 33 (36%) patients were diagnosed with Stage I UC, 15 (16%) with Stage II, 27 (29%) with Stage III and 17 (18%) with Stage IV. The mean age at the time of primary surgery was 69.97 years, and the mean age at death was 73 years. There was an overall recurrence rate of 14% and death rate of 49%. The association between various patient, disease and treatment factors with survival was analysed. Age at diagnosis and stage of disease were both significant predictors of survival odds, with stage IV UC conferring the highest odds of death compared to stage I (OR 12.5, 95% CI 2-79.2), and increasing age at diagnosis demonstrating a small but significant increase in odds ratio for death (OR 1.06, 95% CI 1.005-1.12). However, there were no significant associations between type of adjuvant therapy and recurrence with death following both univariate and multivariate analyses. Conclusion Our cohort of UC cases demonstrated a higher survival rate than that reported in the literature, but recurrence rates were difficult to compare due to the large proportion of women with missing recurrence data (35%). While modality of adjuvant therapy correlated differently with recurrence risk, it was ultimately not significantly associated with any difference in survival. Factors that were significantly predictive of survival were age at diagnosis and stage of disease.
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Treatment of high-grade Vaginal Intra-epithelial Neoplasia (VaIN): A retrospective case series Field, A; Bhagat, N; Speed, T; Razvi, K Obstetrics and Gynaecology, Southend University Hospital, Southend, UK Introduction VaIN is a human papilloma virus (HPV) associated pre-malignant condition, similar to cervical intraepithelial neoplasia. Although cervical cancer screening is not designed to screen for vaginal disease, co-existing lesions may be discovered and appropriate follow-up and treatment needed, to prevent disease progression whilst avoiding unnecessary morbidity. Methods Fifty-three cases of high-grade VaIN (VaIN 2 or 3) occurring between 2005 and 2017 were identified using the colposcopy database and a case note review done. Results The 53 cases comprised 35 VaIN 2 and 18 VaIN 3. Five patients had already undergone hysterectomy including four for cervical abnormalities. In total, 68% of patients with high-grade VaIN had either already had or would go on to have treatment for cervical abnormality. Six cases of high-grade VaIN were treated conservatively with colposcopy six months later. At this stage, three patients had normal colposcopy and the other three had regressed to VaIN 1. However, ultimately, half of the patients treated conservatively for high grade VaIN would go on to have laser treatment. Forty-one cases were treated with laser vaporisation of which ten also had concurrent treatment for a cervical abnormality. There were nine cases (22%) of either persistent or recurrent VaIN after laser treatment. Three patients had persistent high-grade VaIN at first colposcopic follow-up and underwent repeat laser treatment. Six patients had recurrence of VaIN after a period of normal colposcopic follow-up. The average time to recurrence was 673 days after primary treatment. There was one case of progression to vaginal cancer occurring in a background of VaIN 3. A repeat biopsy at the time of laser surgery confirmed malignancy. This was successfully treated with radiotherapy. Of the remaining patients, three were treated with diathermy ablation, two had a localised excisional procedure and one underwent hysterectomy with upper vaginectomy Conclusion High-grade VaIN often co-exists with cervical abnormalities and many will need treatment for both. There are various treatment options for high-grade VaIN including conservative management, although close colposcopic follow-up is needed as approximately 50% need further treatment. Laser surgery is safe and effective although around one-fifth may need further treatment for either persistent or recurrent disease. High-grade VaIN may recur several years after initial treatment meaning a prolonged period of follow-up is necessary. There is a reassuringly low rate of progression to vaginal cancer which remains an uncommon disease. ) and the rest (12.4%) had the bivalent vaccine. 62.9% of women were aged 26 years and below, while 37.1% of women were more than 26 years at the time of the first vaccine dose. More than half of the women were sexually active at the time of vaccination (57.5%) while 42.5% were virgo intacta. Less than half the population completed the entire vaccination schedules (44.3%) and out of these, only 3 women did not complete the vaccinations within a year. 7.9% of women had abnormal cervical smears prior to the start of the vaccination schedule. There were no documented major side effects from these vaccinations, although 1 woman developed urticaria after the first vaccine dose. Conclusion The current HPV vaccination approach in Singapore is not targeting the right population of women for cervical cancer prevention. Further studies looking at the HPV vaccination practice in the community and the population vaccinated is highly recommended. A school based HPV vaccination program needs to be seriously considered to allow for optimal protection against cervical cancer in Singaporean women.
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Outcomes Introduction Our unit is part of the HPV Primary Screening Pilot programme in the UK. HPV screening has a high negative predictive value and high sensitivity but low positive predictive value, as the majority of women who are HR-HPV positive will not have high grade disease. The management algorithms are therefore significantly different from cytology based screening. For example women who are HR-HPV positive and have low grade or negative cytology should be discharged to 3 year recall if they have normal colposcopy or HPV only (rather than traditional 6 month or annual follow-up for low grade patients).
Methods We studied the management and outcomes of HPV positive women with low grade or negative cytology in the HPV primary screening pilot from August 2013 to August 2014 and followed these patients up until May 2016. We first obtained the NHS numbers from the cytology lab for HPV positive patients, and then input their data into Microsoft Excel to be analysed.
Results The HPV Primary Screening Pilot Programme led to a significant increase in both referrals and workload to our unit. This was largely attributed to HPV positive, cytology negative women being seen in colposcopy who previously would not have been identified by screening. 180 patients were identified, of these 21% had negative cytology, 30% had borderline and 49% had low grade. In 59% (107/180) of patients the pilot algorithm was not followed. 78/180 (43%) of the patients who had normal or HPV only colposcopy, who should have been discharged to normal recall but instead had repeat colposcopy. However, 2 patients (3%) who should have been discharged to 3 year recall, subsequently had treatment for CIN 2/3. There were no cancers missed. Conclusion The increase workload noted due to the introduction of primary screening was exacerbated by clinicians' lack of adherence to guidance and reluctance to discharge patients. It was noted that towards the later years of the study period the algorithms were followed more closely as colposcopists became more comfortable with discharging patients back to the GP. Appropriate discharge of these patients will reduce the number of colposcopy appointments, with benefits for patients and service providers, and appears to be safe. We note however the finding of high grade disease in 2 patients who should have had 3 year recall, highlighting the need for long term monitoring of outcomes as the NHSCSP moves towards HPV primary screening.
MEP6319
Evaluating the impact of changing the endometrial thickness threshold for investigating symptoms of post-menopausal bleeding in Addenbrooke's Hospital, Cambridge, UK Background UK national targets mandate that women presenting with symptoms of post-menopausal bleeding (PMB) should be referred for urgent assessment to identify potential gynaecological malignancy. Assessment includes physical examination and evaluation of the endometrium by transvaginal ultrasound scan (TVUS). Recent guidelines have been published by the British Gynaecological Cancer Society advising that women with an endometrial thickness of >4.0 mm should have an endometrial biopsy to assess for underlying pathology. This threshold was lower than the thickness of 5.0 mm currently used in our local PMB clinic. Currently all patients in our unit requiring endometrial biopsy also undergo hysteroscopy. We therefore undertook a baseline review of our PMB clinic to determine how E-Poster Presentations lowering the threshold to 4.0 mm would impact on our service provision, and whether any additional serious pathology would be captured. Objectives To determine the additional burden on local PMB services, should the threshold for endometrial assessment be lowered to 4.0 mm. Methods Data was collected retrospectively for all women attending the PMB clinic during a 12-month period between 2015 and 2016. Results 617 patients with PMB attended clinic, and their mean age was 60.3 years. Of these, 181 (29%) were discharged without endometrial biopsy following TVUS. The remaining 436 (71%) underwent hysteroscopy and endometrial biopsy. There were 72 women (11%) who had an endometrial thickness between 4.0 and 4.9 mm. Of these, 31 (5% of the total) proceeded to hysteroscopy and endometrial biopsy due to risk factors (such as tamoxifen use) or because their scan was inconclusive or showed other endometrial abnormalities such as irregularity. Of these women, none had biopsies that were premalignant or malignant. Forty-two women (7% of the total) had an endometrial thickness between 4.0 and 4.9 mm and no other characteristics warranting investigation, and were thus discharged without hysteroscopy or biopsy under the current criteria. Discussion Lowering the threshold would result in an additional 7% of women requiring endometrial assessment in our local PMB clinic, and this has now been implemented in line with national guidance. To our knowledge, none of those women that would now warrant endometrial assessment have re-presented with malignant pathology. Additionally, none of those with an endometrial thickness between 4.0 and 4.9 mm who did undergo biopsy (due to risk factors) had serious pathology, suggesting the absolute risk remains low. It will be interesting to see how many additional cases of pre-malignant or malignant disease we detect following the change in practice.
MEP6346
Patient experience using DYSIS digital colposcopy in a single centre setting Bhagat, N; Field, A; Speed, T; Clark, S; Razvi, K Department of Obstetrics and Gynaecology, Southend University Hospital, Southend On Sea, UK Objective Cervical cytology and HPV testing have been established for cervical screening in the NHS Cervical Screening Programme in the UK. Women with an abnormal screening test are referred on to colposcopy clinics for a diagnostic evaluation. Colposcopy is an invasive/intimate examination which causes high levels of anxiety in women, especially first time attenders. Dynamic Spectral Imaging (DYSIS) is a NICE approved technology which can be used as an adjunct to colposcopy, which can help make colposcopy a more patient friendly experience, and thus reduce anxiety and non-attendance following abnormal smears.
The objective is to assess patient experience using the DYSIS system versus normal colposcopy and see if it is one such solution.
Methods Dynamic Spectral imaging of the cervix along with colposcopy was used to assess patients who were referred to the cancer centre at Southend University Hospital, UK following abnormal smears as part of the cervical screening programme. We conducted a prospective study on 89 consecutive women attending the colposcopy clinic. A standardized questionnaire was devised with the help of DYSIS Medical Ltd., UK which was filled in by each woman at the end of her clinic visit. They were divided into 2 groups -those who had a prior experience of colposcopy and those who were first time attenders. Results All women (100%), including those who had previous colposcopy, preferred having a DYSIS examination to only colposcopy and were keen on referring their friends and family who required one for DYSIS. On a scale of 0-10, with 0 being 'not at all' and 10 being 'definitely', women who had a previous colposcopy felt that incorporating DYSIS did not unduly prolong their examination and scored a median of 1 (with an average of 2). From both groups, patients felt more relaxed about the procedure after looking at the DYSIS monitor and being able to understand what the colour coded DYSIS areas meant, so much so, it reduced their anxiety levels by 50%. Almost 90% felt that the DYSIS map helped them understand their condition and its significance better, thus reassuring them and potentially reducing their chances of non-attendance. Conclusion Combining DYSIS with colposcopy helps women understand what it is they are being tested for, and makes it a more patient friendly experience, thus ensuring patient understanding and potentially improving their compliance. On investigation her NMDA levels were high so a CT scan was done which showed a complex right adnexal mass 7 9 8 cm in keeping with ovarian teratoma. Preoperative tumor markers were AFP-105 (high), LDH-588 (high). Ca125, Ca19-9 and CEA were normal. In view of her NMDA encephalitis probably secondary to right ovarian teratoma she was posted for surgery the following day after discussion among gynaecology, neurology and ITU team. A Laparotomy and right oophorectomy with peritoneal washings was performed. (Histology-Mature teratoma of right ovary grade 3 ovarian teratoma, Germ cell tumour stage 1A.) Following removal of the teratoma she had intravenous immunoglobulins, plasma exchange and rituximab, in addition to routine supportive care. Subsequently AFP levels dropped to normal slowly. By postoperative day six, she was extubated. She had substantial autonomic instability characterized by tachycardia and fevers, but mental status slowly improved. By one month postoperatively, she was oriented, able to converse clearly without difficulty, with residual short term memory loss. She was transferred to inpatient rehabilitation around one month postoperatively to continue her recovery. She is at a risk of relapse and will need long term follow-up with neurophysicians and gynaecology. Discussion Anti-N-methyl-D-aspartate (NMDA)-receptor encephalitis is a recently (2005) described syndrome of psychiatric symptoms and neurologic sequelae associated with ovarian teratomas. It appears that the incidence of this condition is higher than previously estimated and will continue to increase with improvements in health care and knowledge of the condition. Due to the rarity of anti-NMDA-receptor encephalitis, diagnosis may be delayed while more common conditions, such as primary psychiatric disorders and infectious encephalitis, are ruled out. Age ranged 24-88 with mean age of 49 years. One woman aged 24 years old and not due for screening; 2 women aged 25 at their first ever cytology test were diagnosed ICC. 33% were smokers and 69% were multiparous. Most common type of ICC was squamous (73%). Compliance with NHSCSP in 18 (29%) women, incomplete screening in 21 (34%) women, 11 (18%) never had a smear. 5 women were ceased from recall as they reached the upper limit for screening age. 94% were appropriately referred to either colposcopy clinic or fast tract post-menopausal bleeding clinic. 27 (44%) women were screen detected; 25 of whom were diagnosed at stage 1. 89% of women with screen compliance were at stage 1 at diagnosis, they had curative surgery either at specialist cancer centre or locally. Those who were diagnosed secondary to suspicious symptoms and suspicious cervix (n = 34) tend to be in the advanced stage of stage 2b or above at diagnosis and received either chemotherapy or chemo-radiation. More advanced stage of disease (stage 2 B and above) also seemed to be more common among those who either never attended the cervical screening or who were lapsed attenders. External cytology review required in 4 cases as the ICC was diagnosed within 2 years of last cytology. Conclusion The incidence of invasive cervical cancer at WSHFT during the study period was 10.6% with mortality rate of 24% during the study period. Death from ICC was found among women who either were never or lapsed-attender to NHSCSP. The vital information from the audit should be made awareness to the local population to promote good uptake in cervical screening.
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Establishing a comprehensive cervical cancer prevention activity in Tondo slum, Manila, Philippines Roxas, MR Introduction We retrospectively analyzed the differential clinical features and prognosis of endometrial carcinomas arising from the lower uterus, which are reported to have a poorer prognosis than those arising from the upper uterus. Methods 246 patients with endometrial carcinoma who underwent surgery were entered as subjects.
Results Twenty-three were classified as having lower uterine segment carcinomas (LUSC), the remaining 223 were upper uterine segment carcinomas (UUSC). LUSC cases were associated with a more advanced FIGO stage than UUSC (P < 0.001). Deep myometrial invasion and lymph node metastasis were more common in LUSC than in UUSC (P = 0.006 and P < 0.001, respectively). LUSC cases demonstrated significantly shorter overall survival (OS) and progression-free survival (PFS) than UUSC (P = 0.02 and P < 0.001, respectively). Multivariate cox proportional hazards analysis demonstrated that the hazard ratio for LUSC was 1.769 for OS and 3.479 for PFS. For endometrial carcinoma survival, FIGO stage and histological type were extracted as independent variables. Conclusion LUSC is a high-risk indicator for poorer prognosis for endometrial carcinoma because it is associated with more advanced-stage disease, deep myometrial invasion and lymph node metastasis, and indicates a significantly worsened PFS probability. Our analysis concludes that LUSC is FIGO-stagedependent and an important factor for OS. Introduction Sentinel lymph node biopsy has been widely adopted in the surgical management of women with early stage vulvar cancer, but many patients require inguino-femoral lymphadenectomy (IFL). Following IFL many gynaecologic cancer surgeons drain the groin to prevent lymphocyst formation despite a lack of high quality evidence to support this practice. Our objective was to investigate whether groin drains after IFL are associated with reduced postoperative morbidity in women undergoing surgery for vulvar cancer.
E-Poster Presentations
Methods A retrospective cohort study of women diagnosed with primary vulvar cancer who underwent vulvectomy/radical local excision and unilateral or bilateral IFL was conducted. Cases were ascertained from the weekly outcome reports of a statewide tertiary gynecologic oncology tumor board and cross-referenced with hospital operating room databases. Data including postoperative outcomes were abstracted from medical records. Patients were stratified into one of two groups according to whether a groin drain had, or had not been used.
Results Seventy-one patients were included. Inguinal drains were used in 48 patients (67.6%) and 23 (32.4%) patients did not have their groin wound/s drained. The most common postoperative complications recorded were wound infection (59.2%), groin lymphocyst (32.4%) and cellulitis (25.4%). The mean length of hospital admission was 11.5 (2-40) days. Compared to patients in whom inguinal drains were placed, those in the 'no drain' group had a significantly lower incidence of postoperative groin cellulitis (8.7% versus 25.4% P = 0.039). No significant differences were observed between patients in the 'drain' and 'no drain' groups in lymphocyst formation, wound infection, return to the operating room, duration of hospital stay, readmission post discharge and lower limb lymphedema. Conclusion In this study of patients undergoing inguino-femoral dissection for primary vulvar cancer, postoperative cellulitis occurred less frequently in patients without an inguinal drain. The incidence of other postoperative complications was no different whether a groin drain was used or not. Prospective studies may be warranted.
MEP6839
The role of MRI in predicting response after chemoradiotherapy in locally advanced cervical cancer Jones, D; Nama, V; Patel, A; Cass, G; Plans, C; Platt, S Introduction Cervical cancer is the leading cause of mortality attributed to malignancies in females. In more than 99% of cervical cancers, human papilloma virus has been identified as the causative agent. It has a long preinvasive phase which can be easily identified by cervical screening. Vaccination for human papilloma virus is available and its protective nature against the disease is well established. Although the World Health Organization has repeatedly emphasized on the importance of the cervical screening and HPV vaccination and more than 54 countries are using them but in Pakistan this has not been taken into consideration. Every day twenty women die due to cervical cancer in Pakistan which makes Pakistan second among the entire world with such a huge burden of deaths attributed to cervical carcinoma. Methods This is a qualitative study which incorporates in-depth interviews and three focused group discussions conducted at three tertiary care hospitals in Rawalpindi. The interviews and discussion data was audio taped and then transcribed. Key themes and subthemes were identified. Informed consents were taken from the participants after brief introduction of study and then interviews were conducted.
Result As a result of this study health care providers cited awareness, knowledge, government policies, financial issue, social and religious belief, shortage of skilled staff, unavailability of dedicated clinics, lack of proper recall system are identified as main factors leading towards low uptake of cervical screening and human papilloma virus vaccination. Out of all the identified barriers main was lack of comprehensive government policies regarding the cervical cancer prevention. Conclusion Continuous efforts are required to ensure that government understands the importance of screening of female population and the need for vaccination of young girls. Health care providers may benefit from guidelines and recommendations on increasing awareness among community. Further efforts to increase acceptability of these two should take into consideration the specific needs of the population.
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The two week referral pathway: A boon or a bane? -A cancer unit experience Saralaya, S; Murthy, N Obstetrics and Gynaecology, Conquest Hospital, East Sussex Healthcare Trust, Hastings, UK Introduction The two week referral pathway is in use in the UK to reassure/confirm a diagnosis of cancer, in those women with signs and symptoms of suspected cancer. There has however been a substantial increase through the two week referral across all specialities in the recent years. Our objective was to identify the final diagnosis amongst this cohort within gynaecology. Methods A retrospective notes based audit. All cases referred on the two week referral pathway from 1st December 2016 to 30th September 2017 at East Sussex Healthcare Trust were included. Data was collected using a structured Proforma. Details were recorded under demographics, presenting complaints, comorbidities, time taken from point of referral to being seen at out patient clinic at ESHT, procedure done and histopathology report Results Majority of the women were appropriately triaged and treated as per local cancer network guidelines and 'Improving Cancer Outcome guidance', NHS England. Majority of the women in our study, i.e. 56.2% were referred with post menopausal bleeding, followed by pelvic mass (19.4%), vulval complaints 10%, cervical complaints 8% and irregular bleeding 5.6%. 1.5% had endometrial cancer in the post menopausal bleeding group whereas majority of operated pelvic masses were benign confirming completed treatment and 0.15% of borderline ovarian tumors in final diagnosis. Unfortunately there were one case each of endometrial cancer stage 3a, clear cell cancer of ovary which was undetected on preoperative imaging and tubal adenocarcinoma was detected in a woman who had a risk reduction surgery. Conclusion The two week referral pathway is a useful tool as we are able to flag women with high suspicion of malignancy and subsequently quickly reassure women in whom there is no cancer detected. However it is to be noted that majority of women didn't have a cancer diagnosis in our study and the psychological sequelae of a '2 week referral' is yet to be quantified.
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Post coital bleeding (PCB): Time for action by Royal Colleges as standardised pathways and guidance needed. Outcome of a ten year review of PCB referrals to East Lancashire Teaching Hospitals Colposcopy Services Krishnamoorthy, U; Waddington, T; Choudhry, S Gynecology, East Lancashire Hospitals NHS Trust, East Lancashire, UK Introduction Post coital bleeding (PCB) consists of spotting or bleeding that occurs during or after sexual intercourse can be alarming for patients as is a cardinal symptom of cervical cancer although mostly due to benign causes. There is ambiguity in management of PCB and paucity of national/college guidance. Given the anxiety it evokes in patients and association with cervical cancer, there is the need for streamlined National pathway.
Objectives Review aimed to improve standard of care provided for management of PCB. Objectives were to evaluate current Objective Radical trachelectomy was developed as a fertility sparing procedure for young women diagnosed with early invasive cervical cancer and recent meta-analyses suggest that it is oncologically safe with good obstetric outcomes. Dargent et al first reported the vaginal radical trachelectomy in 1987, whereas the abdominal radical tachelectomy (RAT) was described by Smith et al in 1997. The objective of this study is to analyse the oncological and obstetrical outcomes of women diagnosed with early cervical cancer in a single institution.
Methods This is a retrospective analysis of patients who were diagnosed with early stage cervical cancer and have undergone a fertility sparing RAT and bilateral lymphadenectomy. The data is retrieved from the KK Gynaecological Cancer Centre Database and the review period is from 2010 to 2015. Women who met the inclusion criteria (age less than 40 years and desiring future fertility, lesion less than 2 cm, Stage IA2 to IB1, confirmed invasive carcinoma, no radiological evidence of lymph node or distant disease) were offered RAT.
Results There were 9 patients who met the inclusion criteria and underwent RAT. 78% of the patients were Chinese and 22% were Malay. The average age at diagnosis was 31.7 years of age. The average length of stay in the hospital postoperatively was 5.2 days. Complications wise, there was one complication of thermal ureteric injury for which the patient had ureteric stenting intraoperatively and had no long term urological sequelae. 2 patients suffered from stitch expulsions and 1 patient had Postoperative pelvic infection. The mean disease free interval was 60.4 months and overall survival rate at 3 years of follow-up was 100%. Of the 9 patients, only 6 of the patients tried to conceive by the time of analysis. There were a total of 3 spontaneous pregnancies and 2 live births. Hence the pregnancy rate of the patients who tried to conceive was 33.3% and the livebirth rate was 66.7%. One of the pregnancies resulted in confirmed leaking liquor at 18 + 5 weeks of gestation and the patient underwent a mid-trimester termination of pregnancy. The other two pregnancies were delivered at 36 and 35 weeks of gestation by caesarean section. Conclusion RAT appears to be a feasible fertility sparing procedure in young women diagnosed with early cervical cancer. Despite the small numbers from this series, the oncologic and obstetric outcomes appear promising if strict criteria are used. worldwide 239,000 new cases are diagnosed annually. Two key factors that could improve survival in EOC are early diagnosis and appropriate primary surgery. Preoperative prediction of the malignant potential remains challenging in early stage disease. This is especially true for ovarian masses identified in premenopausal women, and in South-East Asian countries, where the incidence of EOC rises in women in their 30s. Intra-operative frozen section (FS) has been proposed to prevent delay in primary surgery, but suffers from several limitations such as wide variation in accuracy due to large size of cysts, sampling error, and limitation of available staining methods owing to time constraints. Our observational study aimed to investigate haptoglobin within ovarian cyst fluid (OCF) as a diagnostic biomarker for epithelial ovarian cancer (EOC) and develop an in vitro diagnostic point-ofcare device test (IVDPCT) for use in the operating theatre. Methods Proteomic, immunohistochemical and ELISA methods measured haptoglobin in OCF to differentiate benign and EOCs. Diagnostic performance of haptoglobin was compared with CA125, risk malignancy indices (RMI) and frozen section. Blinded validation of the IVDPCT was performed in the laboratory and operation theatres. Results Haptoglobin concentration measured by ELISA was 0.70 AE 0.09 mg/ml in patients with benign cysts (n = 87), 6.22 AE 0.53 mg/ml in early stage-EOC (n = 17), and 6.57 AE 0.65 mg/ml in late stage-EOC (n = 20). Haptoglobin in EOCs was significantly higher than in benign cysts (P < 0.0001). Haptoglobin using rapid colorimetric assay (RCA) on a training set had a sensitivity of 97.3% and a specificity of 92.0%, comparable to ELISA and frozen sections. The haptoglobin AUROC curve was 0.999 (95% CI 0.997-1.000) compared with 0.895 (95% CI 0.814-0.977, P < 0.05) for CA125. Haptoglobin performed significantly better than all the RMIs (P < 0.01). Blinded validation studies showed a minor drop in average diagnostic performance (sensitivity 85.2% and specificity 90.5%) compared with the training set. However, when compared with frozen section, haptoglobin was no worse in diagnostic accuracy for malignancy. Conclusion Haptoglobin was identified as a biomarker for the detection of EOC. Our data suggest the potential utility of OCF haptoglobin as an in vitro diagnostic point-of-care tool with accuracy comparable to that of frozen section.
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An unusual case of PECOMA Bhagwanani, G Obstetrics and Gynaecology, Liverpool Hospital, Sydney, Australia Introduction Perivascular epitheliod cell tumours (PEComas) are defined as 'a mesenchymal tumour composed of histologically and immunohistochemically distinctive perivascular epitheliod cells'. In the 25 years since uterine PEComas were first described, our understanding of PEComas has increased greatly. However, it is still an uncommon neoplasm and more knowledge is required on the subject. Clinical description MF, a 41 year old G6P6, was initially seen in the gynaecology outpatient clinic with a six-year history of abnormal uterine bleeding (AUB), associated with lethargy and dizziness. Pelvic ultrasound revealed a multi-fibroid uterus with an increased endometrial thickness of 2 cm. The patient elected for medical management with Primolut and Tranexamic Acid. However, due to persistent AUB she proceeded with a hysteroscopy and curettage. The histopathology revealed features consistent with a PEComa. MF elected for definitive management, and subsequently had a total abdominal hysterectomy and a bilateral salpingooophorectomy. Final histopathology was consistent with a benign leiomyoma. There were no residual signs of PEComa. Discussion The uterus is the most common site of PEComas of the gynaecological tract. However, due to the limited number of cases available, the characteristics which define malignant potential, as well as prognosis, are unclear. As such, PEComas remain a diagnostic challenge, and optimal management has yet to be established. As seen in this case, preoperative diagnosis may overestimate the risk of malignancy, leading to overtreatment. Conclusion More information on the diagnostic and prognostic features of PEComas is required in order to improve our understanding of the neoplasm and inform our management decisions.
MEP7351
Steroid cell tumor of ovary: A rare occurence in pregnancy Malik, S; Sheikh, SA Obstetrics & Gynecology, King Khalid Hospital, Riyadh, Saudi Arabia Introduction Steroid cell tumors of the ovary are uncommon sex cord-stromal ovarian tumors. Their incidence is only 0.1% of all ovarian tumors. There are three steroid cell tumor subtypes: steroid cell tumor not otherwise specified (NOS), stromal luteomas and leydig cell tumors, out of these NOS constitutes 60% of all steroid cell tumors. The tumors can occur at any age but the mean age of occurrence is 43 years and their occurence in pregnancy is extremely rare. These tumors should be considered a cause of isosexual precocious puberty in children and virilisation in adults such as hirsutism, temporal balding and amenorrhoea. Case A 29 year old female G4P3L3 with 38 weeks POG with previous 2 caesarean admitted with c/o pain abdomen. Patient was evaluated and an USG was done which showed severe oligohydramnios. Patient was taken up for caesarean section. A single alive male baby was extracted with birthweight 3.2 kg and apgar score of 6, 9 at 1 and 5 min. Incidently b/l suspicious ovaries were noted (10 9 8 9 5 cm complex cystic ovaries). There was no ascites or peritoneal implants. Left salpingoophorectomy was done. Sample was sent for HPE. On HPE steroid cell tumor NOS mostly eosinophilic granular cell with focal lipid laden clear cells was diagnosed. There was mild nuclear atypia. Mitotic figures 6/10 HPF in most cellular area. No necrosis and haemorrhage seen. Discussion Steroid cell tumors of the ovary are rare, especially during pregnancy, with only a few reported cases. About 25% of the tumors have no hormonal manifestations with patients experiencing no or vague symptoms such as abdomen pain. Our patient fall in this category as it was an incidental finding intracaesarean. Hayes and Scully found that 25-43% of these tumors are malignant and histologic examination can provide clue. They found that the most accurate predictor of malignant behaviour is mitotic figures more than 2 per 10 high power fields (HPF). Other features are grade 2-3 atypia, necrosis, haemorrhage and a diameter >7 cm. On the basis of these features our patient tumor may behave as malignant nature. Hence patient is being referred to gynaeoncology centre for further treatment. Conclusion In conclusion steroid cell tumors are very rare tumors of the ovary and these must be distinguished from luteoma of pregnancy which is a hyperplastic rather than a neoplastic condition.
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Using frozen section to guide intra-operative management of suspicious ovarian masses Prior, E; Duncan, T; Tyler, X Obstetrics and Gynaecology, Norfolk and Norwich University Hospital, Norwich, UK Women with suspected early-stage ovarian cancer require surgical staging in order to guide further treatment. The British Gynaecology Cancer Society have recently released guidelines advising adequate (non-sparing fertility) primary surgery for these patients which should consist of; peritoneal washings or ascites sampling, total abdominal hysterectomy and bilateral salpingoophorectomy, multiple peritoneal biopsies from para-colic and subdiaphragmatic spaces, omentectomy, and pelvic and para-aortic lymph node assessments. Frozen section (FS) involves carrying out rapid histological assessment of the ovarian mass at the time of surgery. The result of the frozen section will then guide whether full primary staging is necessary. By performing a frozen section it may be possible to avoid unnecessary surgery and, therefore, unnecessary morbidity. This more conservative approach is particularly relevant to those younger patients keen to preserve their fertility. It is important to test the accuracy and usefulness of the addition of frozen section to the clinical decision making and outcome. The objective of this article is to present the most recent dataset from our unit for FS accuracy over a 2 year period. Frozen section versus final histology was tested. 150 intraoperative FS analyses performed between January 2014 and December 2016 were identified. A pre-surgical risk of malignancy index (RMI) less than 200 matched final histology as benign in 43 out of 43 patients, giving a negative predictive value of 100%. However an RMI above 200, had a positive predictive value of 56% for malignancy at final histology. 44% of those patients with an RMI above 200 had borderline or benign histology meaning they would not require surgical staging. FS was reported as 4 categories; benign, borderline, borderline at least or malignant. There were 2 discrepancies amongst the benign FS, which were upgraded to borderline. Within the borderline category 1 was downgraded to benign. For those reported as malignant, there were no discrepancies at final histology. The category 'borderline at least' had a positive predictive value of 66.6% of malignancy. Within our unit intra-operative FS analysis has excellent diagnostic test accuracy and assists the gynaecological oncologists to perform the appropriate surgery. The category 'borderline at least' has been introduced when there is still a high suspicion of malignancy at FS and our results suggest that the chances of having a malignant final histology is over 60% in this subgroup.
MEP7378
A three year retrospective case review of women under the age of 25 years of age, who had high grade changes confirmed on histopathology and the implications, if any, for Australia's new cervical screening guidelines Cooke, M; Kothari, A Maternity, Queensland Health -Redcliffe Hospital, redcliffe , Australia
Introduction Australian cervical screening guidelines as of the 1 December 2017 will recommend cervical screening should commence at 25 years of age instead of 18 years of age. Human Papilloma Virus (HPV) testing, with partial genotyping combined with Liquid Based cytology triaging for HPV positive women will occur now only every five years. This new cervical screening program is predicted to reduce the incidence and mortality from cervical cancer by at least 15%. (Medical Services Advisory Committee 2017.) Aims The aim of this retrospective case series is to look at the number of women, at a non-tertiary Queensland Hospital, over a three year period, whom had high grade changes confirmed on cervical biopsy or Lletz, who were below the age of 25 years. Methods All women, over a three year period, below the age of 25 years, who had a Cat 1 referral to colposcopy clinic were included. The reason for referral, the colposcopy results and histopathology results were tabulated. Overall numbers of women below 25 years of age, and incidence of high grade changes on tissue biopsy were recorded. Results Incidence of High Grade changes confirmed on Histopathology in women under the age of 25 years is not insignificant. 115 Cat 1 referrals were made to colposcopy clinic over a three year period for women under the age of 25 years, the vast majority having high grade cytology results. Of these, 21 women had high grade changes confirmed on histopathology. Conclusion Australia has one of the lowest rates of cervical cancer in the world having an incidence rate of only 6.8 cases per 100,000 females (2013, cancer council of Australia). Even knowing the pathophysiology of HPV and it's oncogenic effects, Is there a possibility that a later entry age and a five year gap between screening may miss women who may have needed treatment? This small case series, at a Queensland hospital, suggests the number of women who are treated for high grade changes prior to 25 years of age in a vaccinated population is not insignificant. Methods 1 year retrospective review of cases seen at the monthly multidisciplinary colposcopy meetings in 2015 to examine the effect on CPC. These case were then followed up for 1 year thereafter to the end of 2016. We look at indications for referral to CPC, concordance between cytology and histopathology, then the subsequent impact it has on management plans. Secondary aim of this study aims to highlight cases discussed during the CPC for educational purposes to highlight the impact it has on clinical education. Results A total of 8 sessions were conducted from January to December 2015. A total of 48 cases were discussed at the CPC. Meetings were held every 1-2 monthly and all meetings were attended at least by histopathologist, cytopathologists and a colposcopist. One of the case was re-presented to further discuss management. Majority of the patients were referred for the indication of discrepency between histology and cytology results. CPC made a change to most of the patient's subsequent management.
MEP7406
Conclusion Multidisciplinary team discussions have long been incorporated into cancer management, but is gradually moving to include non-cancer management recently. CPC is a prime example of such a move and plays an important role in influencing patient management. The impact of CPC on clinical practice remains to be further monitored and audited in our local context. Indonesia. An analysis about the cost-effectiveness of HPV vaccine in Indonesia was done and will be used as the base of the strategy for cervical cancer prevention in Indonesia. This analysis reveal that HPV 6/11/16/18 vaccination of females in Indonesia are (1) substantially reduce genital warts, CIN, and cervical cancer; (2) improve quality of life, and (3) with the Indonesia GDP of USD 3,531.80 in 2014, cost/QALYs result with or without catch up is considered very cost-effective when implemented; however with catch up, the cost/QALY can be better. Although the Indonesian government already has some pilot project to implement the HPV vaccination program for school girls age 10-12 years, still some effort should be made to the huge amount of women at risk those which still are not covered by any of cervical cancer prevention program. Cervical cancer screening with VIA is already used as the only screening program supported by the government for the prevention of cervical cancer in Indonesia, but the coverage of this program is still low. VIA with picture that could be made by a very simple camera is now already used to increase the motivation of the women and the support of the family for those women at risk to have a screening for cervical cancer. VIA's picture is also could help the service provider in increasing their quality in doing the screening with VIA because the VIA's picture also could be used as a tool for consultation and a tool for the VIA program's quality control. 
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